The support of our valued sponsors keeps the cost of tuition at an affordable $395. (Even the most budget-conscious entrepreneurs can attend!) An excellent value, this workshop consists of 2 days of practical and interactive sessions with the ‘movers-and-shakers’ of the medical device community. The registration fee includes all meals with continental breakfast and lunch each day, and a Friday and Saturday evening networking event.

Thanks to our sponsors, a scholarship will be awarded to each successful applicant to defray the majority of workshop costs. Sponsorship is building and presently includes:

The Ewing Marion Kauffman Foundation of Kansas City works with partners to encourage entrepreneurship across America and improve tha educational achievement of children and youth. The Kauffman Foundation was established in the mid-1960's by the late entrepreneur and philanthropist Ewing Marion Kauffman. More information about the Kauffman Foundation is available at

Abbott Vascular Devices, a division of Abbott, is transforming the treatmentof vascular disease, combining the latest medical device innovations with world class pharmaceuticals to advance medicine and improve patient care. Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their, safety, ease of use and effectiveness in treating patients with vascular disease. Abbott Vascular is headquartered in Redwood City, CA.

Delphi Ventures is a venture capital firm focused on early stage healthcare investing, including medical devices, diagnostics and biotechnology. More than 80 of our companies have either completed an initial public offering or have been acquired by leading healthcare corporations.
The partners at De Novo Ventures ( truly understand the issues facing life science entrepreneurs, as they founded and ran some of the most successful companies in the medical device industry, including ACS, Perclose, Origin, CTS, and FoxHollow. De Novo invests in early stage therapeutic medical device and biotechnology companies, and currently has $350 million under management.

Heller Ehrman Venture Law Group attorneys located in 13 cities throughout the United States, Europe and Asia combine senior-level counseling and extensive industry knowledge to help emerging companies grow and prosper. We work in partnership with clients to build and represent deal-intensive emerging growth companies, both public and private, as well as the venture capital and investment banking firms that support them. We draw on our deep bench of experienced technology and life sciences attorneys to provide our clients with focused business and legal advice from incorporation through initial public offering, acquisition and beyond.
Kleiner Perkins Caufield & Byers (KPCB) is an active venture capital partnership headquartered in the San Francisco Bay Area with a large capital base for investment. Since 1972, the company has invested in over 420 technology companies which have accrued market valuations exceeding $300 billion and employ more than 285,000.
Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 2.5 million patients benefit from Medtronic's technology, used to treat conditions such as heart disease, neurological disorders, and vascular illnesses.
morrison forester
Morrison & Foerster has one of the nation’s premier life sciences practices, focusing on corporate finance and intellectual property protection, licensing, and litigation. In recent years, the firm has represented hundreds of life sciences clients in VC financings and M&A transactions. The firm’s Venture Intellectual Property Group, which focuses on performing IP due diligence for both companies and VCs, works with Morrison & Foerster's corporate group to provide full spectrum service for our clients.
Prism VentureWorks, Westwood, MA, is a leading venture capital firm with early-stage investments in communications, business infrastructure software and systems and life sciences. With over $1 billion in capital under management, Prism has earned industry recognition through the firm's depth of entrepreneurial experience and active role with portfolio companies. Prism's access to an established pool of seasoned entrepreneurs and skilled executives, collaborative approach to working with portfolio companies and integrated network of investors contribute to the firm’s investment success. Additional information on Prism Venture Partners can be found at
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The frm is dedicated to investing in outstanding biomedical technology and life science companies. Prospect targets commercially attractive health care enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technology or services with potential for significant investment returns. The firm invests in companies with a broad range of development and financing reqirements including: (a) incubating new companies, (b) investing in first and second venture financing rounds, and (c) participating in later stage public and private companies with proven buisness models requiring expansion capital.
Shay Glenn Group     sdg  
Shay Glenn, LLP is an intellectual property law firm representing early stage medical device companies, the entrepreneurs who found them and the investors who fund them. The firm is early stage itself, founded in October, 2006 by James R. Shay and Benjamin Glenn. Messrs. Shay and Glenn were most recently with Wilson Sonsini Goodrich and Rosati where Mr. Shay founded that firm’s medical device IP group. Since October, the firm has grown to six IP professionals and currently has a total of 15 employees. Shay Glenn, LLP is located in San Mateo, California.
Biodesign is a broad collaboration between faculty and students at Stanford who share a vision for technology innovation in biomedical engineering through, Invention & Discovery, Education, Ethics & Policy, and Technology Transfer. Our mission is to promote the invention and implementation of new health technologies through interdisciplinary research and education at the emerging frontiers of engineering and the biomedical sciences. Biodesign is a thematic area within bio-x, a program supporting multidisciplinary work related to biology.
At Townsend we have assembled a team of attourneys who specialize in protecting your intellectual property. Most of our attourneys have technical degrees to complement their legal education, and many have advanced degrees and industry experience. We have the experience and expertise to respond to our clients specific needs, and we dedicate our best rescources and service toward meetin the goals and buisness objectives of every client.
Canaan   Wilson Sonsini    
Versant Ventures was founded in 1999 and is a leading health care focused venture capital firm specializing in early stage investments in medical devoces, biotechnology and pharmaceuticals. healthcare services, and healthcare informaion technology. Versant's seasoned investment team, with more than 80 years of venture capital and more than 175 years of operating experience, raised its first fund in November 1999. The firm closed a $400 million fund in December 2001, for a total of $670 million under management. Offices are located in Menlo Park and Newport Beach, California.
Wilson Sonsini Goodrich & Rosati's broad range of services and legal disciplines are focused on serving the principal challenges faced by management and the board of directors of business enterprises. The firm, which is headquartered in Palo Alto, California, has offices in Austin, Reston, New York City, Salt Lake City, San Diego, San Francisco and Seattle. For additional information, visit
Canaan   AltaPartners  
Founded in 1979, Advanced Technology Ventures is a bi-coastal venture capital firm with more than $1.4 billion in capital under management. We work closely with entrepreneurial teams in several technology markets, including medical devices, biotechnology, communications, software and services, and IT infrastructure to build emerging-growth business ventures into market leaders. With more than 25 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises.

Alta Partners is a San Francisco-based venture capital firm focused on life sciences investing. Founded in 1996, the firm currently manages $2 billion in committed capital through eight venture fund programs. Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 110 companies in the sector to date.

Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices. For over 25 years Boston Scientific has advanced the process of less-invasive medicine across a wide range of medical specialties. The companies products help physicians and other medical proffessionals improve their patients' quality of life by providing alternatives to surgery that minimize risk, cost, trauma, aftercare, and procedure.
thomas mcnerney   thomas mcnerney   Dorsey LLP
Canaan Partners is an early-stage investor and creates next-generation companies in Internet infrastructure, communications, software and services, medical devices, biological sciences, pharmaceuticals and diagnostics. Founded in 1987, the firm has invested in more than 210 companies, completed 52 mergers and acquisition, and taken 45 companies public. Canaan was an early investor in DoubleClick (DCLK), Immunicon (IMMC), Dexcom (DXCM) and Peninsula Pharmaceuticals.
For more than 40 years, Cordis Corporation, a Johnson and Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation, and a deep understanding of the medical marketplace and the needs of patients has made Cordis the world's leading developer and manufacturer of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. Today 7,000 Cordis employees worldwide share a strong commitment to continue the Company's groundbreaking work in the fight against vascular disease.

Dorsey & Whitney LLP provides a full range of legal services to emerging life science companies from assistance securing initial venture financings and follow-on rounds to helping companies protect and leverage their intellectual property assets and perform due diligence. From the Bay Area and around the world, more than 600 Dorsey attorneys are ready to help emerging companies meet complex legal challenges as they begin and grow their businesses.

Frazier Ventures   Highland Capital Partners   InterWest
Founded in 1991 and with more than $1.2 billion of capital under management, Frazier Healthcare is one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies. Having invested in more than 90 emerging healthcare companies, Frazier Healthcare is well known for its depth of experience and the technical expertise of its investment team. This experience encompasses product development and launch, clinical trial implementation and design, industry operating experience, academic research and clinical practice.

Highland Capital Partners was founded with the mission of helping great people build great companies. Since its inception in 1988, the firm has taken a sector-focused approach to investing in exceptional information technology, communications, consumer and healthcare companies. We have invested in over 170 early and growth stage companies – 75 of which have gone public or been acquired to date. With over $2.6 billion of committed capital, Highland has invested in and worked to create such firms as Ask Jeeves, Avid Technology, Be Free, CheckFree, Conor Medsystems, Continental Cable, Fastclick, Lycos, MapQuest, Ocular Networks, Origin MedSystems, Renal Care Group, Sybase, Telica, US Labs, VistaPrint and WebLine Communications. Recent Highland healthcare investments include BAROnova, Codon Devices, Hyperion Therapeutics, Magen Biosciences, Pervasis Therapeutics, Predictive Biosciences, and RedBrick Health.


InterWest Partners, founded in 1979, is a leading diversified venture capital firm focused on Information Technology and Life Sciences. Currently investing its ninth fund (IW IX), a $600 million fund, InterWest has raised more than $2 billion of capital since inception. 

The firm's investments in life sciences include: Aspreva Pharmaceuticals Corporation (ASPV), Corixa (CRXA; acquired by GlaxoSmithKline, GSK), Epicor Medical (acquired by Saint Jude Medical, STJ), Inspire Pharmaceuticals (ISPH), IntraLase (ILSE; acquired by Advanced Medical Optics, EYE), Myogen (MYOG; acquired by Gilead, GILD), Spinal Dynamics (acquired by Medtronic, MDT) and TheraSense (THER; acquired by Abbott Labs, ABT).

thomas mcnerney   NCIIA   Onset Ventures
Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. jjdc makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies.
The NCIIA was established in 1995 with support from The Lemelson Foundation. Its mission is to foster invention, innovation, and entrepreneurship in higher education – components of the higher education curriculum that are vital to the nation’s economic future.

The NCIIA accomplishes its goals by supporting curricula and programs that encourage the development and the work of E-Teams – multidisciplinary teams of students, faculty, and industry mentors working together to take an idea for a technological innovation and bring it through prototype development to commercialization. The “E” stands for excellence and entrepreneurship.
ONSET Ventures specializes in providing an ideal mix of start-up, follow-on, and intellectual capital to entrepreneurs and early-stage technology ventures, to help transform world-class ideas into sustainable and valuable businesses.

The firm has backed over 100 companies since 1984 and now has more than $700 million under management. ONSET Ventures focuses exclusively on information and medical technology-based start-ups, and has a long history of successful ventures in each of these sectors.
Sanderling   Split Rock Partners   SV Life Sciences
Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling's unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both its entrepreneurs and investors.
Sanderling emphasizes early-stage financing and active management of its portfolio companies. Sanderling and its principals play an active role in new ventures by providing seed and early-stage funding, contributing management leadership and administrative support, developing cost-control strategies to extend available dollars, supplying technical and regulatory expertise where needed, and offering the insight and perspective of those who have "done it before." The Partnership also has sufficient capital to support its companies in later-stage financing.
Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast. We are an early-stage VC firm founded in June 2004 by the former healthcare and software investment teams of St. Paul Venture Capital. The team managed over $1 billion of venture capital while at SPVC and continues to manage the SPVC healthcare and software portfolio. In May 2005, we raised $275 million in our inaugural fund.
SV Life Sciences is a venture capital adviser and manager that makes selected investments in businesses with experienced entrepreneurs and management teams.

SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.6 billion which primarily invest amounts of between $1m and $20m in North America and Europe, but will consider innovative investments in other regions. Our team of 28 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.
Canaan   Canaan    
Founded in 1988, the vertical group is a venture capital firm that is focused on the fields of medical technology and biotechnology. The Vertical Group managesprivate partnerships with a "vertical" range of investments including: early and late venture stage companies; private operating companies involved in buy-out or corporate spin-off transactions; and public companies of all sizes. The Vertical Group has offices in Summit, NJ and Palo Alto, CA .
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fifty important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

Aubrey Group

  Coronis Medical Ventures  
Forsight Labs
Aubrey Group, Inc. located in Irvine, CA employs over 40 engineers in its 43,000 sq.ft. facility. We provide services for the design and manufacturing of electromechanical and disposable medical devices. Specialties include disposable cassettes, custom tubing sets, RF generators, wireless communication, fluidics, implantables, blood processing and cardiovascular assist devices. Services include electronic, software, and mechanical engineering, industrial design, FDA submission, prototypes and flexible contract manufacturing.  Aubrey Group has class 100,000 certified clean room facilities. The company is an FDA-registered developer and manufacturer of medical devices and is ISO 13485:2003 certified. For more information, visit our website at
Coronis Medical Ventures, LLC is a unique seed fund and business accelerator dedicated to providing a blend of capital, venture development and prototyping support for early stage medical device companies. Founded by veteran medical device entrepreneurs and experienced investors, Coronis knows what it takes to develop world-class companies.
Coronis delivers capital, hands-on development, co-invention, leadership, guidance and nurturing as well as access to a staffed and operational FDA-registered pilot and commercial manufacturing facility. This comprehensive approach allows Coronis to expeditiously select and build the most promising new medical technology companies. Coronis is strategically located in Silicon Valley.
ForSight Labs is a community of ophthalmic innovation focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. We have created an environment where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies. Founded in 2005 and based in Menlo Park, CA, ForSight Labs launched its first company, Transcend Medical, Inc. in 2006, and founded its second company, ForSight VISION2 in late 2006.  Our investors include Morgenthaler Venture, Split Rock Partners and Versant Ventures . For more information, please visit the ForSight Labs website at

The Foundry

The Foundry® is the premier medical device company incubator for inventors to rapidly transform their concepts into companies. The Foundry’s highly experienced team of senior technical and business executives has founded and financed ten medical device companies since its inception in 1998. These new medical device businesses have generated over $1.0 billion of value for their founders and investors and employ more than 350 people today, further establishing a proven track record of success. For more information, please visit our website at
Hantel is a contract medical device design and manufacturing company located in the Bay Area. Hantel expedites medical device projects by supplying services from five business units: Engineering, Fabrication, Quality/Doc Control, Manufacturing, and Regulatory. The Engineering Group is experienced in medical device development, including catheters, disposables, surgical instrumentation, electromechanical devices, fixtures, and testing. The Fabrication Group has over 190 years of machining/ prototyping experience and excels at quick-turn projects involving CNC, EDM, mold-making, and other technologies. Hantel’s Quality/ DC Group provides ISO, FDA, and Quality System auditing programs, component inspection services, and can serve as a virtual document control service. The Manufacturing Group provides CER device assembly, materials management, injection molding, and packaging services. The Regulatory Group provides regulatory strategy and documentation support. Hantel's talented multidisciplinary team operates multiple shifts to compress customer time lines, while maintaining FDA and ISO compliance. Clients work with one Hantel Group or all, depending on project scope.
Hiemstra Product Devlopment provides design and engineering services during all stages of medical device development - from early stage feasibility, R&D and clinical builds, through design for manufacturability. Heimstra specializes in the design of unique hand held tools that require a high level of usability including catheder-based delivery systems and minimally invasive surgical devices.

Iatro Design

  The Innovation Factory  
Iatrodesign, LLC is a fusion of expertise in the fields of computer science, graphic design and medicine. We consider ourselves a boutique design house with capabilities that range from simple graphic or web design, to complete database driven customer solutions.
The Innovation Factory finds promising medical technology ideas in their earliest stages, develops them into groundbreaking products, and leads them to market via new companies we launch and manage. By rigorously assessing ideas and investment opportunity, and eliminating the hassles of start-up financing through dedicated venture capital partners, The Innovation Factory is revolutionizing the way medical technology is developed.

MicroCube is a self-sufficient start-to-finish medical device company focused on uncovering clinical needs, developing breakthrough technologies and releasing turnkey product/procedures for clinical use. We concurrently tackle 5 to 10 cutting-edge projects propelled by multi-disciplinary teams of creative problem-solvers with instant access to all necessary capabilities in one space. In-house capabilities include diverse clinical practice knowledge, concept development, design, rapid prototyping and IP management, as well as market mapping, clinical trials and regulatory submissions. MicroCube has a relentlessly open and self-enhancing culture that actively mentors designers, innovators and leaders to find and fulfill their calling as specialists and presidents in the device industry. If your passion is hands-on excellence in medical device innovation, and can bring high energy with a demonstrable competence in design, technology/ prototype development, clinical practice or creative problem-solving, please visit us to explore a relationship.


Schox LLP

  Windhover Information Inc  
At Schox PLC, we understand that patent law is a combination of not just technology and law, but also business. Every single decision we make, from invention evaluation to claim creation, involves an unwavering focus on the business strategy and goals of our clients. With this focus, we help our clients build a valuable patent portfolio, avoid a patent infringement lawsuit, and connect them to our investor network. In short, we offer the perfect patent solution for startup and emerging companies.
Since 1989, Windhover Information Inc. has been providing superior analysis and commentary on health care business strategy, industry dealmaking, marketplace trends, and the world of medical start-ups. The expertise that our editorial and research staff have developed--now consulted and relied upon by the industry's top executives, consultants, bankers and investors--finds voice in our publications, leading-edge conferences, and integrated, highly searchable databases of transactions and commentary. Windhover's editorial goal: to clearly present objective, accurate, fundamentally valuable decision-making information.
Home Agenda Sponsors Faculty & Speakers Who Should Attend Application Network Resources